These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 29157126)

  • 1. Sample size calculations for blinding assessment.
    Landsman V; Fillery M; Vernon H; Bang H
    J Biopharm Stat; 2018; 28(5):857-869. PubMed ID: 29157126
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sample Size Re-Estimation without Breaking the Blind in Clinical Trial.
    Wu CH
    J Biopharm Stat; 2015; 25(5):1114-29. PubMed ID: 25630031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deliberate ignorance: a systematic review of blinding in nursing clinical trials.
    Polit DF; Gillespie BM; Griffin R
    Nurs Res; 2011; 60(1):9-16. PubMed ID: 21127453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Understanding the cluster randomised crossover design: a graphical illustraton of the components of variation and a sample size tutorial.
    Arnup SJ; McKenzie JE; Hemming K; Pilcher D; Forbes AB
    Trials; 2017 Aug; 18(1):381. PubMed ID: 28810895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The blind leading the blind: use and misuse of blinding in randomized controlled trials.
    Miller LE; Stewart ME
    Contemp Clin Trials; 2011 Mar; 32(2):240-3. PubMed ID: 21070890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of blinding on treatment effect size estimate in randomized controlled trials of oral health interventions.
    Saltaji H; Armijo-Olivo S; Cummings GG; Amin M; da Costa BR; Flores-Mir C
    BMC Med Res Methodol; 2018 May; 18(1):42. PubMed ID: 29776394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Follow up after sample size re-estimation in a breast cancer randomized trial for disease-free survival.
    Hade EM; Young GS; Love RR
    Trials; 2019 Aug; 20(1):527. PubMed ID: 31443726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of Major Randomized Trials: Part 3 of a 4-Part Series on Statistics for Clinical Trials.
    Pocock SJ; Clayton TC; Stone GW
    J Am Coll Cardiol; 2015 Dec; 66(24):2757-2766. PubMed ID: 26700838
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blinding in randomized clinical trials: imposed impartiality.
    Hróbjartsson A; Boutron I
    Clin Pharmacol Ther; 2011 Nov; 90(5):732-6. PubMed ID: 21993424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.
    Haahr MT; Hróbjartsson A
    Clin Trials; 2006; 3(4):360-5. PubMed ID: 17060210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of clinical data with breached blindness.
    Chow SC; Shao J
    Stat Med; 2004 Apr; 23(8):1185-93. PubMed ID: 15083477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.
    Fergusson D; Glass KC; Waring D; Shapiro S
    BMJ; 2004 Feb; 328(7437):432. PubMed ID: 14761905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A review of blinding in randomized controlled trials found results inconsistent and questionable.
    Boutron I; Estellat C; Ravaud P
    J Clin Epidemiol; 2005 Dec; 58(12):1220-6. PubMed ID: 16291465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sample size calculations in the presence of competing risks.
    Latouche A; Porcher R
    Stat Med; 2007 Dec; 26(30):5370-80. PubMed ID: 17955563
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Re-estimating the sample size of an on-going blinded trial based on the method of randomization block sums.
    Ganju J; Xing B
    Stat Med; 2009 Jan; 28(1):24-38. PubMed ID: 18837073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Practical aspects of randomization and blinding in randomized clinical trials.
    Bridgman S; Engebretsen L; Dainty K; Kirkley A; Maffulli N;
    Arthroscopy; 2003 Nov; 19(9):1000-6. PubMed ID: 14608321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adaptive extensions of a two-stage group sequential procedure for testing primary and secondary endpoints (II): sample size re-estimation.
    Tamhane AC; Wu Y; Mehta CR
    Stat Med; 2012 Aug; 31(19):2041-54. PubMed ID: 22733687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blinding strategies in the conduct and reporting of a randomized placebo-controlled device trial.
    Houweling AH; Shapiro S; Cohen JM; Kahn SR
    Clin Trials; 2014 Oct; 11(5):547-52. PubMed ID: 24902921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Towards a proposal for assessment of blinding success in clinical trials: up-to-date review.
    Kolahi J; Bang H; Park J
    Community Dent Oral Epidemiol; 2009 Dec; 37(6):477-84. PubMed ID: 19758415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The size of a pilot study for a clinical trial should be calculated in relation to considerations of precision and efficiency.
    Sim J; Lewis M
    J Clin Epidemiol; 2012 Mar; 65(3):301-8. PubMed ID: 22169081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.